Prognostic Values of Transforming Growth Factor-Beta Subtypes in Ovarian Cancer.

Junhan ZhouWenxiao JiangWenbin HuangMiaomiao YeXueqiong Zhu

Published in: BioMed research international (2020)

Higher expression of TGF-β2 functioned as a significant predictor of poor prognosis in women with ovarian cancer, especially those with TP53 mutations or who were undergoing chemotherapy with platins, Taxol, or a platin+Taxol.

Keyphrases

poor prognosis
transforming growth factor
epithelial mesenchymal transition
long non coding rna
locally advanced
squamous cell carcinoma
radiation therapy
chemotherapy induced